Canopy Growth (TSX:WEED) Smoked on Earnings: Should You Buy on Weakness?

Should investors buy Canopy Growth Corp (TSX:WEED)(NYSE:CGC) on its recent post-earnings dip? Or is it time to take profits for good?

| More on:

Don’t say you weren’t warned!

Canopy Growth (TSX:WEED)(NYSE:CGC) got clobbered 7.6% on Friday following the reveal of a weaker-than-expected quarterly report that showed a big loss together with swelling operating expenses. Fellow Fool contributor Karen Thomas did a top-notch job of reviewing the results. In this piece, we’ll try to determine whether it still makes sense for the average Canadian investor to hold shares of the marijuana giant as it loses steam.

You need to spend money to make money, right?

Canopy CEO Bruce Linton’s tone shouldn’t have come as a surprise to investors. Every time Canopy reports a number that’s deep in the red, Linton shrugs it off and provides commentary on his views of the longer-term picture and why near-term losses aren’t a big deal in the grander scheme of things.

“You need to use that capital to build scale. And we did,” said Linton in Canopy’s conference call.

To Linton, it’s all about short-term pain for long-term gain, and with his foot on the gas, he’ll likely have no problem telling prospective marijuana investors to “go buy a bank” if a dividend or lower capital spending is what they seek from his hyper-growth firm.

In terms of profitability, Linton also told analysts that Canopy “would have been a nice, tidy little company, probably quite profitable” if the firm “had stayed” in its high-margin state.

Linton sees margins racing higher at year-end as investments begin paying off, while higher-margin edibles sales start coming into the equation. With Canopy readying to jump on the edibles bandwagon later this year, many investors are wondering if big-name cannabis kings like Canopy could stand to experience another exponential rally.

Should you take Linton’s word for it?

While I am a fan of Linton’s aggressive spending, I also think Canopy has the least upside relative to its peers for many reasons that I outlined in past pieces. Moreover, legal edibles sales will be an industry-wide boon to margins, and although Canopy is getting locked and loaded, so too are other pot players that’ve posted better margins of late.

Sure, Canopy has a deep-pocketed dance partner in its corner and may be perceived as one of the “safer” bets in the space, but investors have to remember that Canopy trades at nearly 80 times sales, making it one of the most expensive stocks on the planet. Canopy could halve several times over and still be considered “expensive” through the eyes of fundamental analysts. By comparison, Canopy makes Shopify, one of Canada’s highest-flying stocks, look like a cheap stock with its hefty 30 times sales multiple.

I can’t say I’m an advocate of buying shares of Canopy after its latest dip. We’re almost a year into legalization, and the “edibles tailwind” that some investors are growing excited about may not be enough to reverse the negative momentum faced by the industry, especially should Canada face an unexpected cannabis oversupply problem going into year-end.

Canopy is a premier cannabis player, but it’s also priced like one. The recent 7.6% drop in Canopy shares would have me worried sick to be an investor.

Stay hungry. Stay Foolish.

Fool contributor Joey Frenette has no position in any of the stocks mentioned. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of Shopify and Shopify. Shopify is a recommendation of Stock Advisor Canada.

More on Cannabis Stocks

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Canopy Growth Stock Jumped 30% Last Month: What’s Going on?

Canopy Growth (TSX:WEED) stock is picking up traction again, making it an enticing weed play to buy on strength.

Read more »

A cannabis plant grows.
Cannabis Stocks

These Threats Facing Canopy Growth Stock Could Justify Selling it

Let's dive into whether Canopy Growth (TSX:WEED) is a top stock investors should buy right now after its recent dip…

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

This BioCannabis Firm Could Explode with Product Approval

This cannabis stock used to be a major name, so where does it stand now?

Read more »

Medicinal research is conducted on cannabis.
Stocks for Beginners

This TSX Health-Care Stock Is a Long-Term Buy for Patient Investors

This TSX stock continues to be one of the best long-term opportunities, if you're patient.

Read more »